# FDA Inspection 1158875 - Royal Biologics, Inc. - November 16, 2021

Source: https://www.keypedia.com/records/fda_inspections/royal-biologics-inc/296f9d6c-2bfe-452a-821d-4e3ac78dcf06
Source feed: FDA_Inspections

> FDA Inspection 1158875 for Royal Biologics, Inc. on November 16, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1158875
- Company Name: Royal Biologics, Inc.
- Inspection Date: 2021-11-16
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1274983 - 2025-06-25](https://www.keypedia.com/records/fda_inspections/royal-biologics-inc/c8180ada-c3ff-44ff-802f-aca3bf77d4ca)
- [FDA Inspection 1274983 - 2025-06-25](https://www.keypedia.com/records/fda_inspections/royal-biologics-inc/996bb926-c923-4ef7-9d17-ff9a152480eb)
- [FDA Inspection 1274983 - 2025-06-25](https://www.keypedia.com/records/fda_inspections/royal-biologics-inc/692aafa7-2288-4f1d-bd41-2b7d49c126c4)
- [FDA Inspection 1158875 - 2021-11-16](https://www.keypedia.com/records/fda_inspections/royal-biologics-inc/b073ca11-46bc-49d4-a00b-b6811ed8a1ad)
- [FDA Inspection 1158875 - 2021-11-16](https://www.keypedia.com/records/fda_inspections/royal-biologics-inc/7b7243d0-de94-4cf7-9770-4f0a20393bf8)

Company: https://www.keypedia.com/companies/royal-biologics-inc/fc2f3d6d-713f-49de-ae40-068b91c7cefa

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d